Andreas Daiber Selected Research

Angiotensin II

3/2024	Role of inflammatory signaling pathways involving the CD40-CD40L-TRAF cascade in diabetes and hypertension-insights from animal and human studies.
1/2021	Direct comparison of inorganic nitrite and nitrate on vascular dysfunction and oxidative damage in experimental arterial hypertension.
5/2020	Regulation of Vascular Function and Inflammation via Cross Talk of Reactive Oxygen and Nitrogen Species from Mitochondria or NADPH Oxidase-Implications for Diabetes Progression.
1/2020	Exacerbation of adverse cardiovascular effects of aircraft noise in an animal model of arterial hypertension.
1/2020	Endothelial GLP-1 (Glucagon-Like Peptide-1) Receptor Mediates Cardiovascular Protection by Liraglutide In Mice With Experimental Arterial Hypertension.
10/2019	Comparison of Mitochondrial Superoxide Detection Ex Vivo/In Vivo by mitoSOX HPLC Method with Classical Assays in Three Different Animal Models of Oxidative Stress.
1/2019	T Cell-Derived IL-17A Induces Vascular Dysfunction via Perivascular Fibrosis Formation and Dysregulation of ·NO/cGMP Signaling.
1/2019	Endothelial α1AMPK modulates angiotensin II-mediated vascular inflammation and dysfunction.
12/2018	α1AMPK deletion in myelomonocytic cells induces a pro-inflammatory phenotype and enhances angiotensin II-induced vascular dysfunction.
1/2018	CD40L controls obesity-associated vascular inflammation, oxidative stress, and endothelial dysfunction in high fat diet-treated and db/db mice.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Andreas Daiber Research Topics

Disease

59	Inflammation (Inflammations) 03/2024 - 03/2011
37	Hypertension (High Blood Pressure) 03/2024 - 08/2005
33	Cardiovascular Diseases (Cardiovascular Disease) 01/2023 - 10/2010
18	Heart Failure 07/2023 - 08/2005
12	Atherosclerosis 01/2022 - 04/2007
10	Coronary Artery Disease (Coronary Atherosclerosis) 01/2020 - 04/2007
8	Type 2 Diabetes Mellitus (MODY) 07/2023 - 01/2014
8	Diabetes Mellitus 01/2020 - 08/2005
7	Reperfusion Injury 04/2023 - 04/2011
7	Hypoxia (Hypoxemia) 05/2020 - 06/2010
7	Vascular Diseases (Vascular Disease) 01/2019 - 01/2005
6	Hyperlipidemias (Hyperlipidemia) 03/2024 - 04/2003
6	Hyperglycemia 02/2023 - 10/2011
6	Myocardial Infarction 10/2022 - 07/2009
5	Psoriasis (Pustulosis Palmaris et Plantaris) 07/2023 - 12/2014
5	Body Weight (Weight, Body) 07/2023 - 09/2008
5	Skin Diseases (Skin Disease) 07/2023 - 12/2014
5	Myocardial Ischemia (Ischemic Heart Diseases) 10/2022 - 11/2011
5	Ischemia 10/2022 - 01/2010
5	Infarction (Infarctions) 10/2022 - 07/2009
5	Stroke (Strokes) 10/2022 - 04/2011
5	Fibrosis (Cirrhosis) 01/2022 - 01/2017
5	Neoplasms (Cancer) 11/2021 - 04/2006
5	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 10/2021 - 09/2008
5	Obesity 01/2020 - 01/2016
4	Thrombosis (Thrombus) 02/2024 - 11/2013
4	Cardiomyopathies (Cardiomyopathy) 10/2022 - 02/2007
4	Acute Coronary Syndrome 01/2020 - 05/2014
3	Cardiotoxicity 11/2019 - 02/2007
2	Anxiety Disorders (Anxiety Disorder) 10/2022 - 11/2020
2	Septic Shock (Toxic Shock Syndrome) 06/2022 - 03/2015
2	Heart Diseases (Heart Disease) 01/2022 - 01/2021
2	Pre-Eclampsia (Preeclampsia) 01/2022 - 01/2020
2	Sepsis (Septicemia) 07/2021 - 10/2012
2	Endotoxemia 07/2021 - 03/2015

Drug/Important Bio-Agent (IBA)

25	Reactive Oxygen Species (Oxygen Radicals)IBA 07/2023 - 08/2005
22	NitratesIBA 01/2021 - 08/2005
21	Angiotensin IIIBA 03/2024 - 10/2006
18	AntioxidantsIBA 02/2023 - 09/2008
15	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2023 - 04/2003
15	Superoxides (Superoxide)IBA 10/2022 - 08/2005
11	CytokinesIBA 02/2024 - 01/2005
11	Proteins (Proteins, Gene)FDA Link 02/2024 - 11/2006
11	EnzymesIBA 02/2023 - 09/2008
11	Oxygen (Dioxygen)IBA 01/2023 - 01/2011
11	NitrogenIBA 01/2023 - 01/2011
9	Nitric Oxide (Nitrogen Monoxide)FDA Link 06/2022 - 08/2005
9	Nitroglycerin (Dynamite)FDA LinkGeneric 01/2021 - 11/2006
8	Hormones (Hormone)IBA 12/2023 - 01/2018
7	Glucose (Dextrose)FDA LinkGeneric 07/2023 - 10/2012
7	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2022 - 03/2015
6	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2018
6	Interleukin-6 (Interleukin 6)IBA 10/2021 - 12/2018
6	Pentaerythritol Tetranitrate (Pentalog)IBA 01/2021 - 02/2010
6	Messenger RNA (mRNA)IBA 01/2021 - 05/2014
5	Interleukin-17 (Interleukin 17)IBA 02/2024 - 12/2014
5	RNA (Ribonucleic Acid)IBA 02/2024 - 01/2021
5	Streptozocin (Streptozotocin)FDA Link 10/2019 - 05/2008
4	empagliflozinIBA 07/2023 - 01/2014
4	Retinaldehyde (Retinal)IBA 04/2023 - 01/2019
4	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2021 - 02/2007
4	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 10/2021 - 01/2011
4	sapropterin (tetrahydrobiopterin)FDA Link 10/2021 - 06/2008
4	Liraglutide FDA Link 07/2021 - 03/2015
4	IronIBA 05/2021 - 04/2006
4	3-nitrotyrosineIBA 01/2021 - 11/2012
4	ApolipoproteinsIBA 01/2021 - 04/2007
4	LinagliptinIBA 01/2018 - 10/2012
4	isosorbide-5-mononitrate (Ismo)FDA LinkGeneric 01/2018 - 10/2011
4	Nitric Oxide Synthase (NO Synthase)IBA 02/2014 - 11/2006
3	Transcription Factors (Transcription Factor)IBA 03/2024 - 01/2018
3	SodiumIBA 07/2023 - 01/2014
3	SymportersIBA 07/2023 - 01/2014
3	Oxidants (Oxidizing Agents)IBA 01/2023 - 01/2014
3	Phosphotransferases (Kinase)IBA 01/2023 - 01/2021
3	NitritesIBA 03/2022 - 01/2018
3	Glucagon-Like Peptide-1 Receptor AgonistsIBA 01/2022 - 01/2020
3	Particulate MatterIBA 03/2021 - 11/2020
3	Apolipoproteins E (ApoE)IBA 01/2021 - 04/2007
3	Xanthine OxidaseIBA 01/2021 - 08/2005
3	Dipeptidyl-Peptidase IV InhibitorsIBA 01/2020 - 03/2015
3	Telmisartan (Micardis)FDA Link 08/2019 - 09/2008
3	Heme Oxygenase-1IBA 01/2019 - 08/2010
3	Isosorbide Dinitrate (Isordil)FDA LinkGeneric 01/2018 - 12/2005
3	Blood Glucose (Blood Sugar)IBA 01/2018 - 09/2008
2	Nicotine FDA Link 02/2024 - 01/2020
2	Hemoglobins (Hemoglobin)IBA 07/2023 - 03/2015
2	ResveratrolIBA 04/2023 - 04/2019
2	Imiquimod (Aldara)FDA LinkGeneric 11/2022 - 01/2019
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 10/2022 - 08/2013
2	Air Pollutants (Pollutants, Air)IBA 11/2021 - 06/2020
2	Insulin (Novolin)FDA Link 10/2021 - 01/2011
2	LipopolysaccharidesIBA 07/2021 - 03/2015
2	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 07/2021 - 03/2015
2	Environmental Pollutants (Pollutants, Environmental)IBA 02/2021 - 11/2020
2	Betulinic AcidIBA 01/2021 - 04/2011
2	Nitric Oxide Synthase Type I (Neuronal Nitric Oxide Synthase)IBA 01/2021 - 10/2018

Therapy/Procedure

32	Therapeutics 10/2022 - 09/2008
3	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 10/2021 - 01/2018
2	Ligation 07/2021 - 01/2016